It is estimated that some 50 million Americans experience chronic pain. Significant improvements in the treatment of pain have given many a new lease of life.
Pain management is one of the fastest growing industries in this country and, with their exponential growth, clinics devoted exclusively to this field has come a dramatic increase in the use of drugs-of-abuse, point of care devices.
The devices are generally used to monitor risk management as well as prescription compliance. CLIA Waived
is the fastest growing segment of this market due to minimal laboratory regulations.
BioTech Screening offers both cups and dip devices which are able to test for up to 14 drugs of abuse.